Visit KQAK 105.7
Visit The Peak 104.1
Visit 95.7 The Ranch
Visit 92.5 The Ticket
Visit KBNW 104.5AM AND 1340AM
Recent Quotes
My Watchlist
Indicators
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CEVA, Inc. - Common Stock (NQ:CEVA)

37.10 +1.58 (+4.45%)
Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CEVA, Inc. - Common Stock

< Previous 1 2 3 4 Next >
News headline image
CEVA Inc (CEVA) Q1 2021 Earnings Call Transcript ↗
CEVA earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
40 Stocks Moving In Monday's Mid-Day Session ↗
Gainers Protagenic Therapeutics, Inc. (NASDAQ: PTIX) shares jumped 64.2% to $3.4962 on above-average news. Obalon Therapeutics, Inc. (NASDAQ: OBLN) gained 35% to $2.97. Cue... 
Via Benzinga
News headline image
CEVA Shares Fall After Q1 Earnings Miss, Licensing Revenue Decline ↗
CEVA Inc (NASDAQ: CEVA) reported first-quarter FY21 revenue growth of 8% year-on-year to $25.4 million, beating the analyst consensus of $24.01 million. A 56... 
Via Benzinga
Topics Earnings
News headline image
12 Information Technology Stocks Moving In Monday's Pre-Market Session ↗
Gainers SemiLEDs (NASDAQ:LEDS) stock rose 19.37% to $9.49 during Monday's pre-market session. The market value of their outstanding shares is at $38.5 million.... 
Via Benzinga
News headline image
Recap: CEVA Q1 Earnings ↗
Shares of CEVA (NASDAQ:CEVA) were unchanged after the company reported Q1 results. Quarterly Results Earnings per share decreased 90.91% over the past year to $0.01, which... 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.